European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD)

You might also be interested in reading Ethereum L2 Platform Blast Draws $400M in a Week Despite Invite-Only Access and Criticism.